Using nasal nitric oxide testing to improve diagnosis of primary ciliary dyskinesia
Official title: A Clinical Study to Gather Data on the Utility of Tests That Are Used to Make a Diagnosis of Primary Ciliary Dyskinesia (PCD)
Run by Connecticut Children's Medical Center · NCT05889013 · Data updated 2026-11-12
This study is testing if a simple nasal test can help doctors diagnose primary ciliary dyskinesia in people aged 2 and older who show symptoms of the condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 2 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Connecticut Children's Medical Center Academic / other |
| Locations | 1 site (Hartford, Connecticut) |
| Status | Recruiting |
| Started | October 17, 2023 |
| Main results expected | December 2027 |
| Study ends | December 2028 |
| Registry record updated | October 5, 2026 |
| Trial ID | NCT05889013 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 2 years and older with clinical symptoms suggestive of primary ciliary dyskinesia.
✕Probably not a fit
Patients with recent sinus surgery, current respiratory exacerbations, or those unable to tolerate the testing may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect data on the effectiveness of nasal nitric oxide testing as a diagnostic tool for primary ciliary dyskinesia (PCD). Participants will be referred by pulmonary providers based on clinical symptoms suggestive of PCD. The study will enroll individuals aged 2 years and older who meet specific clinical criteria and provide informed consent. The goal is to enhance the diagnostic approach for PCD by gathering real-world data on this non-invasive testing method.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic accuracy for patients with primary ciliary dyskinesia.
How similar studies have gone: While the use of nasal nitric oxide testing is gaining traction, extensive data from everyday clinical practice is still limited, making this approach somewhat novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 2 years of age * Must have two of the following clinical history points: * Neonatal respiratory distress * Chronic nasal congestion/runny nose * Chronic cough * Situs/laterality defects * Bronchiectasis * Ability to provide informed consent or consent of parent/guardian and ass Exclusion Criteria: * Recent history of sinus surgery or bloody nose in the past week * Age \< 2 years of age * Inability to tolerate probe in nose * Sinusitis or other respiratory exacerbation currently being treated with antibiotics * Admitted to hospital for respiratory exacerbation (inpatient status) * Inability to understand the requirements of the study or be unwilling to provide written informed consent (as evidenced by signature on an informed consent document approved by the IRB) * Any other reason for which the study investigators feel the patient is not a good candidate to complete the testing
Where it's running
-
Pulmonary Division
Hartford, Connecticut, United States Recruiting
Study contacts
- Principal investigator: Melanie S Collins, MD — Connecticut Children's Medical Center
- Study coordinator: Melanie S Collins, MD
- Email: mcollin@connecticutchildrens.org
- Phone: 860-545-9440
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bronchial hyperresponsiveness in children with primary ciliary dyskinesia
This will see if children with primary ciliary dyskinesia have sensitive airways (bronchial hyperresponsiveness) by using a methacholine breathing challenge and related tests.
-
PALMIRE cohort: phenotyping inflammatory lung diseases to enable personalized care
This project will collect clinical, imaging, and biological data from adults with asthma, COPD, bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, or interstitial lung disease to try to identify disease subtypes and markers that could guide more personalized care.
-
Thermal spa treatment to improve symptoms of primary ciliary dyskinesia
We will try a 3-week thermal spa treatment in adults with primary ciliary dyskinesia to see if it improves ear, nose, and throat symptoms, lowers infection and antibiotic rates, and helps hearing and lung function.
-
Glycine and magnesium plus thiamine for primary ciliary dyskinesia
This trial will test whether daily oral glycine and magnesium with thiamine, alone or combined, can help people aged 5 and older with primary ciliary dyskinesia clear mucus and breathe better.
-
Observational study on Primary Ciliary Dyskinesia
This study looks at people with Primary Ciliary Dyskinesia to see what factors might affect how severe their condition is and to help improve their care.
-
Nasal nitric oxide testing for better care in primary ciliary dyskinesia
This study is trying to see if measuring nitric oxide in the nose can help doctors diagnose primary ciliary dyskinesia more accurately for patients at Arkansas Children's Hospital.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.